Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy
NCT05132738
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Stromal Tumors
Interventions
DRUG:
Ripretinib treatment
Sponsor
RenJi Hospital